HK1165997A1 - 喹唑啉二酮衍生物在心血管領域的治療應用 - Google Patents

喹唑啉二酮衍生物在心血管領域的治療應用

Info

Publication number
HK1165997A1
HK1165997A1 HK12106684.4A HK12106684A HK1165997A1 HK 1165997 A1 HK1165997 A1 HK 1165997A1 HK 12106684 A HK12106684 A HK 12106684A HK 1165997 A1 HK1165997 A1 HK 1165997A1
Authority
HK
Hong Kong
Prior art keywords
therapeutic applications
cardiovascular field
quinazolinedione derivatives
quinazolinedione
derivatives
Prior art date
Application number
HK12106684.4A
Other languages
English (en)
Inventor
Philip Janiak
Gilbert Marciniak
Jean-Franois Nave
Fabrice Viviani
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HK1165997A1 publication Critical patent/HK1165997A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK12106684.4A 2009-04-09 2012-07-09 喹唑啉二酮衍生物在心血管領域的治療應用 HK1165997A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901755A FR2944206B1 (fr) 2009-04-09 2009-04-09 Applications therapeutiques dans le domaine cardiovasculaire de derives de quinazolinedione
PCT/FR2010/050672 WO2010116090A1 (fr) 2009-04-09 2010-04-07 Applications thérapeutiques dans le domaine cardiovasculaire de dérivés de quinazolinedione

Publications (1)

Publication Number Publication Date
HK1165997A1 true HK1165997A1 (zh) 2012-10-19

Family

ID=41181038

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106684.4A HK1165997A1 (zh) 2009-04-09 2012-07-09 喹唑啉二酮衍生物在心血管領域的治療應用

Country Status (35)

Country Link
US (1) US8846654B2 (zh)
EP (1) EP2416777B1 (zh)
JP (1) JP5685578B2 (zh)
KR (1) KR101686267B1 (zh)
CN (1) CN102458409B (zh)
AR (1) AR076232A1 (zh)
AU (1) AU2010233596B2 (zh)
BR (1) BRPI1010256A2 (zh)
CA (1) CA2758234A1 (zh)
CL (1) CL2011002525A1 (zh)
CO (1) CO6440577A2 (zh)
CR (1) CR20110527A (zh)
CY (1) CY1115987T1 (zh)
DK (1) DK2416777T3 (zh)
DO (1) DOP2011000306A (zh)
EA (1) EA020984B1 (zh)
EC (1) ECSP11011377A (zh)
ES (1) ES2528633T3 (zh)
FR (1) FR2944206B1 (zh)
HK (1) HK1165997A1 (zh)
HR (1) HRP20150106T1 (zh)
HU (1) HUE024161T2 (zh)
IL (1) IL215610A (zh)
MA (1) MA33254B1 (zh)
MX (1) MX2011010645A (zh)
NI (1) NI201100180A (zh)
NZ (1) NZ595660A (zh)
PL (1) PL2416777T3 (zh)
PT (1) PT2416777E (zh)
SG (2) SG10201400420PA (zh)
SI (1) SI2416777T1 (zh)
TN (1) TN2011000506A1 (zh)
TW (1) TWI457330B (zh)
UY (1) UY32555A (zh)
WO (1) WO2010116090A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944282B1 (fr) * 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
WO2013184806A1 (en) 2012-06-05 2013-12-12 University Of Kansas Inhibitors of respiratory syncytial virus
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
WO2024038089A1 (en) 2022-08-18 2024-02-22 Mitodicure Gmbh Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879393A (en) * 1973-06-18 1975-04-22 Miles Lab Derivatives of 1,3-disubstituted 2,4(1h,3h)-quinazolinediones
JPS56164172A (en) * 1980-05-22 1981-12-17 Masayuki Ishikawa Novel 2,4 1h,3h -quinazolinedione derivative
EP0040793B1 (en) * 1980-05-22 1985-08-28 Masayuki Ishikawa Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
US5624926A (en) 1993-02-18 1997-04-29 Kyowa Hakko Kogyo Co., Ltd. Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
BR9909781A (pt) 1998-04-20 2000-12-19 Fujisawa Pharmaceutical Co Composto de formula (i), processo para sua preparação, composição farmacêutica compreendendo dito composto, seu uso e método.
AU2525701A (en) 1999-12-14 2001-06-25 Sanofi-Synthelabo Derivatives of quinazolinedione phthalimide, preparations thereof and their therapeutic uses
WO2006092692A1 (en) 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AU2006219643A1 (en) 2005-03-01 2006-09-08 Pfizer Limited Use of PDE7 inhibitors for the treatment of neuropathic pain
WO2007067946A2 (en) 2005-12-07 2007-06-14 The Regents Of The University Of California Diagnosis and treatment of chronic lymphocytic leukemia (cll)
BRPI0809244A2 (pt) 2007-03-27 2014-09-23 Omeros Corp Métodos de tratamento de uma anormalidade de movimento, e para identificação de um agente que inibe a atividade pde7.
TW200911755A (en) 2007-04-19 2009-03-16 Astellas Pharma Inc Bicyclic heterocyclic compounds
FR2921926B1 (fr) * 2007-10-03 2009-12-04 Sanofi Aventis Derives de quinazolinedione,leur preparation et leurs applications therapeutiques.
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione

Also Published As

Publication number Publication date
US8846654B2 (en) 2014-09-30
IL215610A (en) 2013-07-31
ECSP11011377A (es) 2011-11-30
CY1115987T1 (el) 2017-01-25
NZ595660A (en) 2013-03-28
DK2416777T3 (en) 2015-02-09
MA33254B1 (fr) 2012-05-02
FR2944206A1 (fr) 2010-10-15
PL2416777T3 (pl) 2015-05-29
AU2010233596B2 (en) 2016-06-23
SG175131A1 (en) 2011-11-28
US20120184522A1 (en) 2012-07-19
SI2416777T1 (sl) 2015-02-27
UY32555A (es) 2010-11-30
CA2758234A1 (fr) 2010-10-14
AU2010233596A1 (en) 2011-11-03
CN102458409B (zh) 2014-06-18
KR101686267B1 (ko) 2016-12-13
NI201100180A (es) 2012-01-11
CL2011002525A1 (es) 2012-02-17
EP2416777A1 (fr) 2012-02-15
BRPI1010256A2 (pt) 2016-03-22
AR076232A1 (es) 2011-05-26
PT2416777E (pt) 2015-02-04
EA201171229A1 (ru) 2012-12-28
KR20120005499A (ko) 2012-01-16
EP2416777B1 (fr) 2014-11-12
EA020984B1 (ru) 2015-03-31
TN2011000506A1 (fr) 2013-05-24
WO2010116090A1 (fr) 2010-10-14
TW201040155A (en) 2010-11-16
TWI457330B (zh) 2014-10-21
JP5685578B2 (ja) 2015-03-18
SG10201400420PA (en) 2014-05-29
CO6440577A2 (es) 2012-05-15
HUE024161T2 (hu) 2016-02-29
CR20110527A (es) 2014-05-12
IL215610A0 (en) 2011-12-29
FR2944206B1 (fr) 2012-12-28
HRP20150106T1 (hr) 2015-05-08
DOP2011000306A (es) 2011-10-31
ES2528633T3 (es) 2015-02-11
CN102458409A (zh) 2012-05-16
MX2011010645A (es) 2012-01-19
JP2012523398A (ja) 2012-10-04

Similar Documents

Publication Publication Date Title
EP2440050A4 (en) TRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATION
EP2440051A4 (en) TRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
GB2478595B (en) Phytocannabinoids in the treatment of glioma
EP2440056A4 (en) DERIVATIVES OF UREIDOPHENYL SUBSTITUTED TRIAZINE AND THERAPEUTIC APPLICATIONS THEREOF
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
EP2440052A4 (en) TRIAZINE DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF
IL218212A0 (en) Therapeutic methods and compositions
HRP20130538T1 (en) Therapeutic uses of quinazolinedione derivatives
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
ZA201107363B (en) Quinazolinedione derivatives,preparation thereof and various therapeutic uses thereof
ZA201108458B (en) Nitrile derivatives and their pharmaceutical use and compositions
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
EP2490541A4 (en) 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE
IL216831A (en) History of triazine and their medical applications
EP2592083A4 (en) CONDENSED QUINAZOLINE DERIVATIVES AND USES THEREOF
HK1165997A1 (zh) 喹唑啉二酮衍生物在心血管領域的治療應用
EP2440055A4 (en) STYRYLTRIAZINE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
ZA201203286B (en) Therapeutic and diagnostic applications against trypanosomosis
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
HK1173995A1 (zh) 二茂鐵喹在治療瘧疾中的用途
GB0920650D0 (en) The medicinal uses of molecules and their derivatives
PL388613A1 (pl) Nowa 7-O-n-pentylo-5-O-metylo-8-prenylonaringenina oraz sposób jej otrzymywania
GB0906044D0 (en) Nalmefene compositions and their therapeutic use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190410